Medicon Valley, one of the most important life sciences clusters in Europe

Medicon Valley, one of the most important life sciences clusters in Europe

Medicon Valley is the name for the vibrant biomedical ecosystem of the Nordic countries and stretches from the Greater Copenhagen metropolitan area through eastern Denmark to the southernmost part of Sweden.

With 44,000 employees in the life sciences industry and 14,600 life sciences university researchers spread across nine universities, Medicon Valley is the heart of Northern Europe’s life sciences where high professional standards and infrastructure are combined. with an enviable quality of life.

Thanks to our investment in Learning to Sleep, I have been gradually assimilating the impact and depth of this ecosystem. Here are some figures worth noting:

It has more than 350 biotechnology, medical technology and pharmaceutical companies with local R&D

– 5 multinational biopharmaceutical companies; Ferring, McNeil, Novo Nordisk, Lundbeck, and LEO Pharma
– 44,000 employees in the private life sciences sector
– 9 life sciences colleges with 24,000 life sciences students
– 14,600 life science researchers
– 6,000 doctoral students related to life sciences and health
– 7 science parks with a main focus on life sciences (with a total of 1,500 companies)
– 10 incubators
– 9 university hospitals (28 hospitals in total)
– They are constantly renewing or expanding their infrastructure to do world-class research.

Medicon Valley is known in Europe for its pioneering research in cancer and inflammation, but also offers cutting-edge expertise in neurology, cardiology, metabolic disease, cell therapy and the microbiome.

As with any innovation cluster, Medicon Valley’s ‘whole’ is greater than the sum of its parts. Their approach allows them to detect synergies and use their events and activities to create a rich exchange of ideas, knowledge and services. The interesting thing, at least for me, has been realizing that not everything has to revolve around Silicon Valley or Boston and that there is plenty of room to do business and biomedical developments of the highest quality in places like Stockholm or Copenhagen.

You just have to dare, establish contact and expand networks. Who knows? Perhaps our adventure with Learning to Sleep is the beginning of a large collaboration with the Nordic countries, a link that already exists, but in other industries and areas of human activity.

Medicon Valley is the name for the vibrant biomedical ecosystem of the Nordic countries and stretches from the Greater Copenhagen metropolitan area through eastern Denmark to the southernmost part of Sweden.

 

With 44,000 employees in the life sciences industry and 14,600 life sciences university researchers spread across nine universities, Medicon Valley is the heart of Northern Europe’s life sciences where high professional standards and infrastructure are combined. with an enviable quality of life.

 

Thanks to our investment in Learning to Sleep, I have been gradually assimilating the impact and depth of this ecosystem. Here are some figures worth noting:

 

It has more than 350 biotechnology, medical technology and pharmaceutical companies with local R&D

 

– 5 multinational biopharmaceutical companies; Ferring, McNeil, Novo Nordisk, Lundbeck, and LEO Pharma

– 44,000 employees in the private life sciences sector

– 9 life sciences colleges with 24,000 life sciences students

– 14,600 life science researchers

– 6,000 doctoral students related to life sciences and health

– 7 science parks with a main focus on life sciences (with a total of 1,500 companies)

– 10 incubators

– 9 university hospitals (28 hospitals in total)

– They are constantly renewing or expanding their infrastructure to do world-class research.

 

Medicon Valley is known in Europe for its pioneering research in cancer and inflammation, but also offers cutting-edge expertise in neurology, cardiology, metabolic disease, cell therapy and the microbiome.

 

As with any innovation cluster, Medicon Valley’s ‘whole’ is greater than the sum of its parts. Their approach allows them to detect synergies and use their events and activities to create a rich exchange of ideas, knowledge and services. The interesting thing, at least for me, has been realizing that not everything has to revolve around Silicon Valley or Boston and that there is plenty of room to do business and biomedical developments of the highest quality in places like Stockholm or Copenhagen.

 

You just have to dare, establish contact and expand networks. Who knows? Perhaps our adventure with Learning to Sleep is the beginning of a large collaboration with the Nordic countries, a link that already exists, but in other industries and areas of human activity.

Deja un comentario

Subscribe

Enter your information here and find out the latest news about science and business.